Our Lab Director and BIOEMTECH co-founder, Dr. Maritina G. Rouchota participates at the Conference of COMULIS COST Action that takes place at the. The Cyprus Institute in Nicosia on September 21 and 22. Maritina presents “BIOEMTECH preclinical platform to non-invasively study in vivo biodistribution of nanoparticles”. Nanoparticles are promising carriers for both diagnosis and treatment of various diseases; however their transfer to clinics requires careful preclinical validation steps both in vitro and in vivo. We are happy to share our experience from the participation in several international projects and ongoing preclinical studies and how molecular imaging can speed up this process
21 September 2022